Keytech: Actively exploring optimizing existing research and development processes through AI.

On September 2nd, Keyi Technology stated on the interactive platform that the company has preliminarily formed and continuously strengthened the computational biology team to actively explore optimizing the existing research and development processes through AI, especially in key areas such as drug structure design and molecular screening. The company aims to achieve a more scientific and efficient decision-making process to promote the research and development process of innovative applications of polyethylene glycol materials. As of now, the company has not achieved any significant research and development results through AI, nor will it have a significant impact on the company's performance in the short term. However, the company recognizes the enormous potential of AI technology in improving research and development efficiency and reducing research and development costs.